US Patent:
20110009384, Jan 13, 2011
Inventors:
Taisuke Tawaraishi - Osaka, JP
Hiroshi Imoto - Palo Alto CA, US
Nobuo Cho - Osaka, JP
International Classification:
A61K 31/55
C07D 403/02
A61K 31/4155
A61K 31/4184
C07D 471/04
A61K 31/437
C07D 401/02
A61K 31/4709
C07D 417/14
A61K 31/427
C07D 413/14
A61K 31/4245
A61K 31/5377
C07D 403/14
C07D 401/14
A61K 31/454
A61P 3/10
US Classification:
51421202, 5483647, 514406, 5483061, 514394, 546113, 514300, 546152, 514314, 548183, 514369, 548132, 514364, 544140, 5142308, 540543, 546201, 514323
Abstract:
The present invention provides an agent for the prophylaxis or treatment of diabetes, which has a superior hypoglycemic action, and is associated with a fewer side effects such as body weight gain and the like.The resent invention relates an agent for the prophylaxis or treatment of diabetes, which comprises a compound represented bywherein each symbol is as defined in the description, or a salt thereof or a prodrug thereof.